ASP Isotopes Inc. Common Stock

ASPI trades with a 22.1% short interest ratio—notably elevated for a $700M microcap—despite sitting 48.5 on the RSI, suggesting neither overbought nor oversold momentum. The absence of a P/E ratio flags unprofitability or minimal earnings, typical for early-stage isotope producers still building production capacity. That high short concentration creates structural squeeze potential if sentiment shifts, though the stock sits well below its 52-week peak, indicating prior enthusiasm has cooled considerably. The risk-reward setup hinges entirely on whether ASPI's isotope business reaches commercialization; current valuation reflects deep uncertainty about execution.